Thieler Law Corp Announces Investigation of DBV Technologies S.A.

Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of DBV Technologies S.A. (NASDAQ: DBVT) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of DBV Technologies S.A. (NASDAQ: DBVT) concerning whether a series of statements by DBV Technologies S.A. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On December 19, 2018, the Company revealed that following discussions with the FDA, its Biologics License Application for Viaskin Peanut in children four to eleven years of age has been voluntarily withdrawn.

According to the Company, "although the agency did not reference any medical or clinical questions with the submission of Viaskin Peanut, the FDA did communicate that the level of detail with regards to data on manufacturing and quality controls was insufficient in the BLA."

Following this news, NASDAQ: DBVT fell $8.39, or nearly 60%, to close at $5.76 on December 20, 2018.

Based in Montrouge, France, and founded in 2002 DBV Technologies S.A. engages in the research and development of epicutaneous immunotherapy products.

If you purchased shares of DBV Technologies S.A. (NASDAQ: DBVT) on or before December 19, 2018, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185